B
VKTX icon

Braidwell’s Viking Therapeutics VKTX Stock Holding History

Braidwell’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-759,455
Closed -$20M – 87
2025
Q3 		$20M Sell
759,455
-678,100
-47% -$20.2M 0.59% 46
2025
Q2 		$38.1M Buy
1,437,555
+1,600
+0.1% +$42.1K 1.3% 28
2025
Q1 		$34.7M Sell
1,435,955
-43,711
-3% -$1.38M 1.22% 35
2024
Q4 		$59.5M Buy
1,479,666
+322,689
+28% +$18.4M 1.77% 22
2024
Q3 		$73.2M Buy
1,156,977
+50,072
+5% +$2.94M 2.08% 17
2024
Q2 		$58.7M Buy
1,106,905
+393,805
+55% +$25.8M 1.84% 22
2024
Q1 		$58.5M Buy
+713,100
New +$31.7M 1.88% 18

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return